IAG Cargo adds Strasbourg to its network

This station will facilitate global transport of vital cargo like vaccines, drugs, and clinical trial medication.

IAG Cargo adds Strasbourg to its network
Listen to this Article

IAG Cargo, the cargo division of International Airlines Group (IAG), has added Strasbourg to its network as its latest station in Europe. The newly established station in Strasbourg is to be approved for the transportation of pharmaceuticals requiring precise time and temperature control to IAG Cargo’s hubs in Madrid and London for further distribution. Leveraging IAG Cargo’s extensive network, which connects six continents, this station will facilitate the global transport of critical cargo such as vaccines, medicinal drugs, and clinical trial medication, mentions the official release by IAG Cargo.

This service will be especially beneficial for pharmaceutical customers in France, whose products often transit through London-Heathrow or Madrid on their way to final destinations.

With this addition, the total number of Constant Climate stations for temperature-sensitive transport in Europe reaches 29, and over 100 globally. This expansion follows recent openings in Cincinnati and Cape Town, highlighting IAG Cargo's ongoing efforts to broaden its global network, says the release.

“We are thrilled to announce the opening of another Constant Climate station, this time in Strasbourg, France. As France’s pharmaceutical sector continues to expand, this station comes at an ideal time to support our customers in delivering life-saving medicines and vaccines efficiently. I’m really looking forward to working with our partners and customers in the region to ensure seamless temperature-controlled air cargo services for their critical shipments,” says Jordan Kohlbeck, Head of Pharmaceutical at IAG Cargo.

With an 18% increase in tonnage in 2023 compared to 2022, IAG Cargo's Constant Climate product is a key focus area. It is a cutting-edge cold chain solution designed specifically for the transportation of pharmaceuticals, such as vaccines, biotech products, diagnostics samples, or any other temperature-sensitive pharmaceutical material, the release added.

Read Full Article
Next Story
Share it